The Biology of HIFα Proteins in Cell Differentiation and Disease

Vitamins and Hormones

Volumn 87, Issue , 2011, Pages 367-379

  González, Inmaculada Royo ^a   Moreno Manzano, Victoria ^b   Rodríguez Jimenez, Francisco Javier ^b   Sepúlveda, Pilar ^b,c   Sánchez Puelles, José María ^a,d  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b MGM Integrated Solutions   (Spain)

^c CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Cancer; Cell differentiation; HIF; Stemness

Indexed keywords

EID: 84857132363     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386015-6.00036-6     Document Type: Chapter

References (62)

1. Aaltonen L.A., Peltomäki P., Leach F.S., Sistonen P., Pylkkänen L., Mecklin J.P., Järvinen H., Powell S.M., Jen J., Hamilton S.R., et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993, 260:812-816.
2. Akita T., Murohara T., Ikeda H., Sasaki K., Shimada T., Egami K., Imaizumi T. Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Lab. Invest. 2003, 83:65-73.
3. Anokye-Danso F., Trivedi C.M., Juhr D., Gupta M., Cui Z., Tian Y., Zhang Y., Yang W., Gruber P.J., Epstein J.A., Morrisey E.E. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011, 8:376-388.
4. 2 availability on human cancer. Nat. Rev. Cancer 2008, 8:967-975.
5. Bilton R.L., Booker G.W. The subtle side to hypoxia inducible factor (HIFalpha) regulation. Eur. J. Biochem. 2003, 270:791-798.
6. Bolli R., Shinmura K., Tang X.L., Kodani E., Xuan Y.T., Guo Y., Dawn B. Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. Cardiovasc. Res. 2002, 55:506-519.
7. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., Guenther M.G., Kumar R.M., Murray H.L., Jenner R.G., Gifford D.K., Melton D.A., et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956.
8. Clarke M.F., Fuller M. Stem cells and cancer: Two faces of eve. Cell 2006, 124:1111-1115.
9. Del Peso L., Castellanos M.C., Temes E., Martin-Puig S., Cuevas Y., Olmos G., Landazuri M.O. The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen. J. Biol. Chem. 2003, 278:48690-48695.
10. Eckert A., Kloor M., Giersch A., Ahmadi R., Herold-Mende C., Hampl J.A., Heppner F.L., Zoubaa S., Holinski-Feder E., Pietsch T., Wiestler O.D., von Knebel Doeberitz M., et al. Microsatellite instability in pediatric and adult high-grade gliomas. Brain Pathol. 2007, 17:146-150.
11. Fishel R., Lescoe M.K., Rao M.R., Copeland N.G., Jenkins N.A., Garber J., Kane M., Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993, 75:1027-1038.
12. Folkman J. Angiogenesis: An organizing principle for drug discovery?. Nat. Rev. Drug Discov. 2007, 6:273-286.
13. Franovic A., Holterman C.E., Payette J., Lee S. Human cancers converge at the HIF-2a oncogenic axis. Proc. Natl. Acad. Sci. USA 2009, 106:21306-21311.
14. Geary J., Sasieni P., Houlston R., Izatt L., Eeles R., Payne S.J., Fisher S., Hodgson S.V. Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC). Fam. Cancer 2008, 7:163-172.
15. Harms K.M., Li L., Cunningham L.A. Murine neural stem/progenitor cells protect neurons against ischemia by HIF-1alpha-regulated VEGF signaling. PLoS One 2010, 5:e9767.
16. Hu C.J., Wang L.Y., Chodosh L.A., Keith B., Simon M.C. Differential roles of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in hypoxic gene regulation. Mol. Cell. Biol. 2003, 23:9361-9374.
17. Keith B., Simon M.C. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007, 129:465-472.
18. Key J., Scheuermann T.H., Anderson P.C., Daggett V., Gardner K.H. Principles of ligand binding within a completely buried cavity in HIF2r PAS-B. J. Am. Chem. Soc. 2009, 131:17647-17654.
19. Kido M., Du L., Sullivan C.C., Li X., Deutsch R., Jamieson S.W., Thistlethwaite P.A. Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J. Am. Coll. Cardiol. 2005, 46:2116-2124.
20. Kim H.W., Haider H.K., Jiang S., Ashraf M. **Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J. Biol. Chem. 2009, 284:33161-33168.
21. Kim W.Y., Perera S., Zhou B., Carretero J., Yeh J.J., Heathcote S.A., Jackson A.L., Nikolinakos P., Ospina B., Naumov G., Brandstetter K.A., Weigman V.J., et al. HIF2α cooperates with RAS to promote lung tumorigenesis in mice. J. Clin. Invest. 2009, 119(8):2160-2170.
22. Kondo A., Safaei R., Mishima M., Niedner H., Lin X., Howell S.B. Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repair. Cancer Res. 2001, 61:7603-7607.
23. Lambrechts D., Storkebaum E., Morimoto M., Del-Favero J., Desmet F., Marklund S.L., Wyns S., Thijs V., Andersson J., van Marion I., Al-Chalabi A., Bornes S., et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 2003, 34:383-394.
24. Lisy K., Peet D.J. Turn me on: Regulating HIF transcriptional activity. Cell Death Differ. 2008, 15:642-649.
25. Loor G., Schumacker P.T. Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion. Cell Death Differ. 2008, 15:686-690.
26. Lu X., Kang Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin. Cancer Res. 2010, 16:5928-5935.
27. Majmundar A.J., Wong W.J., Simon C.S. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 2010, 40:294-309.
28. Masui S., Nakatake Y., Toyooka Y., Shimosato D., Yagi R., Takahashi K., Okochi H., Okuda A., Matoba R., Sharov A.A., Ko M.S., Niwa H. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 2007, 9(6):625-635.
29. Mazumdar J., Hickey M.M., Pant D.K., Durham A.C., Sweet-Cordero A., Vachani A., Jacks T., Chodosh L.A., Kissil J.L., Simon M.C., Keith B. HIF-2 alpha deletion promotes Kras-driven lung tumor development. Natl. Acad. Sci. USA 2010, 107:14182-14187.
30. McCord A.M., Jamal M., Shankavaram U.T., Lang F.F., Camphausen K., Tofilon P.J. Physiologic oxygen concentration enhances the stem-like properties of CD133+human glioblastoma cells in vitro. Mol. Cancer Res. 2009, 7(4):489-497.
31. Moreno-Manzano V., Rodríguez-Jiménez F.J., Aceña-Bonilla J.L., Fustero-Lardíes S., Erceg S., Dopazo J., Montaner D., Stojkovic M., Sánchez-Puelles J.M. FM19G11, a new HIF modulator, affect stem cell differentiation status. J. Biol. Chem. 2009, 285(2):1333-1342.
32. Moreno-Manzano V., Rodríguez-Jiménez F.J., García-Roselló M., Laínez S., Erceg S., Calvo M.T., Ronaghi M., Lloret M., Planells-Cases R., Sánchez-Puelles J.M., Stojkovic M. Activated spinal cord ependymal stem cells rescue neurological function. Stem Cells 2009, 27:733-743.
33. Ono M., Maruyama T., Masuda H., Kajitani T., Nagashima T., Arase T., Ito M., Ohta K., Uchida H., Asada H., Yoshimura Y., Okano H., et al. Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells. PNAS 2007, 104(47):18700-18705.
34. Palojoki E., Saraste A., Eriksson A., Pulkki K., Kallajoki M., Voipio-Pulkki L.M., Tikkanen I. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H2726-H2731.
35. Patel S.A., Simon M.C. Biology of hypoxia-inducible factor-2alpha in development and disease. Cell Death Differ. 2008, 15:628-634.
36. Patel N., Gonsalves C.S., Yang M., Malik P., Kalra V.K. Placenta growth factor induces 5-lipoxygenase-activating protein to increase leukotriene formation in sickle cell disease. Blood 2009, 113:1129-1138.
37. Peng Y.J., Nanduri J., Khan S.A., Yuan G., Wang N., Kinsman B., Vaddi D.R., Kumar G.K., Garcia J.A., Semenza G.L., Prabhakar N.R. Hypoxia-inducible factor 2alpha (HIF-2alpha) heterozygous-null mice exhibit exaggerated carotid body sensitivity to hypoxia, breathing instability, and hypertension. Proc. Natl. Acad. Sci. USA 2011, 108:3065-3070.
38. Pichiule P., Chavez J.C., LaManna J.C. Hypoxic regulation of angiopoietin-2 expression in endothelial cells. J. Biol. Chem. 2004, 279:12171-12180.
39. Polyak K., Hahn W.C. Roots and stems: Stem cells in cancer. Nat. Med. 2006, 12:296-300.
40. Pouysségur J., Dayan F., Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006, 441:437-443.
41. Prado-Lopez S., Conesa A., Arminan A., Martinez-Losa M., Escobedo-Lucea C., Gandia C., Tarazona S., Melguizo D., Blesa D., Montaner D., Sanz-Gonzalez S., Sepulveda P., et al. Hypoxia promotes efficient differentiation of human embryonic stem cells to functional endothelium. Stem Cells 2010, 28(3):407-418.
42. Quintana E., Shackleton M., Sabel M.S., Fullen D.R., Johnson T.M., Morrison S.J. Efficient tumour formation by single human melanoma cells. Nature 2008, 456:593-599.
43. Rakhit R., Cunningham P., Furtos-Matei A., Dahan S., Qi X.F., Crow J.P., Cashman N.R., Kondejewski L.H., Chakrabartty A. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J. Biol. Chem. 2002, 277:47551-47556.
44. Rankin E.B., Giaccia A.J. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 2008, 15:678-685.
45. Rankin E.B., Rha J., Unger T.L., Wu C.H., Shutt H.P., Johnson R.S., Simon M.C., Keith B., Haase V.H. Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice. Oncogene 2008, 27:5354-5358.
46. Raval R.R., Lau K.W., Tran M.G., Sowter H.M., Mandriota S.J., Li J.L., Pugh C.W., Maxwell P.H., Harris A.L., Ratcliffe P.J. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol. Cell. Biol. 2005, 25:5675-5686.
47. Rodríguez-Jiménez F.J., Moreno-Manzano V., Lucas-Dominguez R., Sánchez-Puelles J.M. Hypoxia causes downregulation of mismatch repair system and genomic instability in stem cells. Stem Cells 2008, 26:2052-2062.
48. Rodríguez-Jiménez F.J., Moreno-Manzano V., Mateos-Gregorio P., Royo I., Erceg S., Murguia J.R., Sánchez-Puelles J.M. FM19G11 A new modulator of hif that links mTOR activation with the DNA damage checkpoint pathways. Cell Cycle 2010, 9(14):2803-2813.
49. Rosova I., Dao M., Capoccia B., Link D., Nolta J.A. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 2008, 26:2173-2182.
50. Rubio D., Garcia S., Paz M.F., De la Cueva T., Lopez-Fernandez L.A., Lloyd A.C., Garcia-Castro J., Bernad A. Molecular characterization of spontaneous mesenchymal stem cell transformation. PLoS One 2008, 3(1):e1398.
51. Scheuermanna T.H., Tomchicka D.R., Machiusa M., Guoa Y., Bruicka R.K., Gardnera K.H. Artificial ligand binding within the HIF2_ PAS-B domain of the HIF2 transcription factor. PNAS 2009, 106(2):450-455.
52. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 2003, 3:721-732.
53. Semenza G.L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010, 29:625-634.
54. Shyu K.G., Wang M.T., Wang B.W., Chang C.C., Leu J.G., Kuan P., Chang H. Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat. Cardiovasc. Res. 2002, 54:576-583.
55. Simon M.C., Keith B. The role of oxygen availability in embryonic development and stem cell function. Nat. Rev. Mol. Cell Biol. 2008, 9:285-296.
56. Soucek T., Cumming R., Dargusch R., Maher P., Schubert D. The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 2003, 39:43-56.
57. Takahashi K., Yasmanaka S.Y. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
58. Tian H., Hammer R.E., Matsumoto A.M., Russell D.W., McKnight S.L. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev. 1998, 12:3320-3324.
59. Visvader J.E., Lindeman G. Cancer stem cells in solid tumors: Accumulating evidence and unresolved questions. Nat. Rev. Cancer 2008, 8:755-768.
60. Wang G.L., Semenza G.L. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction. Blood 1993, 82:3610-3615.
61. Yuan J., Glazer P.M. Mutagenesis induced by the tumor microenvironment. Mutat. Res. 1998, 400:439-446.
62. Yuan J., Narayanan L., Rockwell S., Glazer P.M. Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH. Cancer Res. 2000, 60:4372-4376.